Patent · US Active

Erythrocytes containing arginine deiminase

US9125876B2 · kind B2 · utility

15Cited by

4References

8Claims

0Family size

Assignee

ERYTECH PHARMA · FR

Inventors

Yann Godfrin · Val-de-Reuil, FR
Pierre-Olivier Goineau · Val-de-Reuil, FR

Key dates

Filing date	Apr 25, 2006
Grant date	Sep 8, 2015
Priority date	—
Expiry date	Apr 23, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Use of erythrocytes containing arginine deirainase for the preparation of a medicinal product for lowering the plasma concentration of arginine in vivo. The use relates in particular to the treatment of arginine-dependent tumors, such as hepatocarcinoma and malignant melanoma, or inhibition of the synthesis of nitric oxide, and the prevention and/or treatment of septic shock.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.